awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39010100-353E4301-ECE1-4E6B-899A-1877A5E1090C
Q39010100-353E4301-ECE1-4E6B-899A-1877A5E1090C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39010100-353E4301-ECE1-4E6B-899A-1877A5E1090C
Rapamycin combined with celecoxib enhanced antitumor effects of mono treatment on chronic myelogenous leukemia cells through downregulating mTOR pathway.
P2860
Q39010100-353E4301-ECE1-4E6B-899A-1877A5E1090C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39010100-353E4301-ECE1-4E6B-899A-1877A5E1090C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
50e071b6c9428d53d64f81aa9005f5084683bc81
P2860
Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.